Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Valderma is an established topical antibacterial and antiseptic medicinal product used primarily for the treatment of skin conditions such as spots, acne, and minor skin infections. It is formulated as a cream or soap and contains two primary active ingredients: **potassium hydroxyquinoline sulphate** (0.2% w/w) and **chlorocresol** (0.2% w/w). Potassium hydroxyquinoline sulphate provides both antibacterial and antifungal properties, while chlorocresol serves as a potent antiseptic and disinfectant. The product works by reducing the bacterial load on the skin's surface, helping to clear existing spots and prevent new ones from forming. Historically associated with major pharmaceutical companies like Roche and Bayer, the brand is currently managed by consumer health specialists such as Optima Consumer Health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Valderma.